Evidence map›Paper›PMID 41404273›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Consensus-Based Definitions for Vocal Biomarkers: The International VOCAL Initiative.

Megane Pizzimenti, Ayush Kalia, Jamie A Toghranegar, Mohamed Ebraheem, Nicholas Cummins, Satrajit S Ghosh, James T Anibal, Rhoda Au, Arian Azarang, Ruth H Bahr and 16 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Megane PizzimentiORCID 0000-0003-3703-4805
Jamie A ToghranegarORCID 0009-0007-4113-8806
Lampros C KourtisORCID 0000-0003-1332-0655
Jaskanwal Deep Singh SaraORCID 0000-0002-0673-0253
Marisha L SpeightsORCID 0000-0002-5466-5484
Bridge2AI Voice Consortium
eVoiceNet COST Action (CA24128)
Jean-Christophe Belisle-PiponORCID 0000-0002-8965-8153
Yael E BensoussanORCID 0000-0002-1635-8627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceVoice-based health technologies are growing rapidly, but they lack standardized terminology, which hinders interdisciplinary collaboration, research quality, and clinical translation.

objectiveThe objective of this work is to develop universally accepted definitions in the rapidly evolving field of vocal biomarkers, as part of the VOCAL (Vocal Biomarker Guidelines for Ontology, Classification, Application, and Logistics) initiative, a structured, international consensus-based framework that aims to provide standards, and guidelines.

designVOCAL is a rigorous, international, multi-stage consensus-building study conducted in 2024-2025.

settingMulti-institutional collaboration between representatives from the Bridge2AI-Voice Consortium (North America) and the eVoiceNet Network (European Union), culminating in an in person workshop at the 2025 Bridge2AI Voice Symposium.

participantsA group of 24 international experts in medicine, clinical research, speech and language, audio signal processing, statistics, methodology, regulation, ethics.

methodsVOCAL's iterative process involved five rounds of review, feedback, and an in-person workshop at the international 2025 Bridge2AI Voice Symposium, ensuring the incorporation of diverse perspectives and achieving a robust agreement on the proposed definitions. MAIN OUTCOMES AND MEASURES: Consensus-based definitions for vocal biomarkers, spanning from broad concepts (biomarker, digital biomarker, vocal biomarker) to domain-specific measures (cardio-respiratory acoustic, voice, speech/articulatory, cognitive/language).

resultsA hierarchical continuum model of vocal biomarkers was established. We first distinguished between the concepts of vocal measures and vocal biomarkers. We then defined terms from broad, overarching concepts (Level 0: Biomarker, Digital Biomarker, Vocal Biomarker) to more specific physiological and cognitive domains (Level 1: Cardio-Respiratory Acoustic; Level 2: Voice; Level 3: Speech/Articulatory; Level 4: Cognitive/Language, including linguistic and paralinguistic subtypes). CONCLUSIONS AND RELEVANCE: This work provides a shared vocabulary that is essential for fostering communication through interdisciplinary collaboration, improving the quality and efficiency of research and development, and ensuring the ethical, reliable, and scalable deployment of future voice-based health technologies. It lays foundational groundwork for upcoming guidelines and standards, which are crucial for advancing the field of vocal biomarkers into widespread clinical utility.

Identifiers

PMID41404273
PMCPMC12704633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.